Kim Dao Yimin Lu Cody J Peer William D Figg Raphael Stadelmann Michel Burnier Thierry Buclin Sebastien Kissling
10.1007/s00280-016-3219-z
Cancer Chemother Pharmacol
2017 Jan;79(1):215-218.
high cut-off membrane high-flux dialysis lenalidomide pharmacokinetics
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/27988790/
Angiogenesis Inhibitors / pharmacokinetics Kidney Failure, Chronic / therapy Multiple Myeloma / drug therapy Renal Dialysis Thalidomide / analogs & derivatives
Angiogenesis Inhibitors / pharmacokinetics Kidney Failure, Chronic / therapy Multiple Myeloma / drug therapy Renal Dialysis Thalidomide / analogs & derivatives Case Reports Aged Female Humans Lenalidomide Thalidomide / pharmacokinetics Angiogenesis Inhibitors Thalidomide Lenalidomide
PMC6410697
27988790
Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure
2017